Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 21.4 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 17 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 16.3 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 15.3 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 18.3 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 17.2 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 18.5 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 30.9 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | C | 0.0 | BCD100427B001 | 18.1 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | C | 0.5 | BCD100427B003 | 24.4 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | C | 1.0 | BCD100427B007 | 17.6 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | C | 2.0 | BCD100427B011 | 17 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | C | 4.0 | BCD100427B015 | 20.3 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | C | 8.0 | BCD100427B019 | 22.4 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | C | 12.0 | BCD100427B023 | 28.4 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | C | 24.0 | BCD100427B027 | 22.9 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 17.6 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 15.2 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 17.4 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 16.9 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 26.6 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 17.2 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 24.1 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol | 0.5 | BCD100427B004 | 18.7 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol | 1.0 | BCD100427B008 | 17.6 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol | 2.0 | BCD100427B012 | 15.7 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol | 4.0 | BCD100427B016 | 18.5 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol | 8.0 | BCD100427B020 | 18.3 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol | 12.0 | BCD100427B024 | 15.8 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol | 24.0 | BCD100427B028 | 25.2 | pmol/sample |